Senator Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-900,000
Closed -$55.8M 128
2020
Q4
$55.8M Buy
+900,000
New +$55.3M 1.05% 35
2020
Q3
Sell
-2,500,000
Closed -$8.9M 60
2020
Q2
$8.9M Sell
2,500,000
-500,000
-17% -$29.9M 0.31% 43
2020
Q1
$11.5M Buy
3,000,000
+500,000
+20% +$30.6M 0.42% 31
2019
Q4
$7.69M Buy
+2,500,000
New +$143M 0.21% 38

Other funds holding BMY

Senator Investment Group's BMY Position: Q1 2021 in Review

Senator Investment Group sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 900,000 shares — an estimated $55.8M sold.

Senator Investment Group first reported a position in BMY in Q4 2019 and held it in 4 quarters. The position peaked at $55.8M in Q4 2020. 2,369 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

  • Senator Investment Group reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
  • Senator Investment Group sold 900,000 Bristol-Myers Squibb shares in Q1 2021, an estimated $55.8M.
  • Senator Investment Group first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 4 quarters.
  • Senator Investment Group's Bristol-Myers Squibb position peaked at $55.8M in Q4 2020.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Senator Investment Group's 13F filing for Q1 2021, filed 17 May 2021.